nitrobenzylthioinosine 5'-monophosphate has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lynch, TP; Paran, JH; Paterson, AR | 1 |
| Adjei, AA; Dagnino, L; Paterson, AR; Wong, MM | 1 |
2 other study(ies) available for nitrobenzylthioinosine 5'-monophosphate and Leukemia L 1210
| Article | Year |
|---|---|
Therapy of mouse leukemia L1210 with combinations of nebularine and nitrobenzylthioinosine 5'-monophosphate.
Topics: Animals; Biological Transport, Active; Drug Therapy, Combination; Inosine; Leukemia L1210; Mice; Purine Nucleosides; Ribonucleosides; Thioinosine; Thionucleotides | 1981 |
Protection against fludarabine neurotoxicity in leukemic mice by the nucleoside transport inhibitor nitrobenzylthioinosine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Hindlimb; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Nervous System Diseases; Paralysis; Prodrugs; Thioinosine; Thionucleotides; Vidarabine | 1992 |